NEW YORK, Dec. 10, 2018 /PRNewswire/ -- InvestAcure,
PBC, a Common Need Investment firm for Alzheimer's R&D,
announced today that David Weild IV,
Former Vice Chairman of the NASDAQ, frequently referred to as "The
Father of the JOBS Act," will join the company as Co-founder &
Vice Chairman of its board of directors.
Mr. Weild is the Founder, Chairman and CEO of Weild & Co.
The studies that he co-authored have documented the long-term
decline in equity capital formation in the United States and provided the core
arguments that gave rise to the JOBS Act and many of its specific
provisions. For these reasons, he is frequently called "The Father
of the JOBS Act." Mr. Weild is a former Vice Chairman and executive
committee member of The NASDAQ Stock Market and spent years running
major Wall Street investment banking and equity capital markets
businesses.
InvestAcure is a Public Benefit Corporation, building a spare
change investment platform to enable all who share a 'Common Need'
to see Alzheimer's cured, to automatically round-up day-to-day
transactions to the nearest dollar and invest their spare-change in
companies working on developing effective medications for the
disease.
Mr. Weild said, "Alzheimer's is a crisis that as of yet
has no solution. Left unchecked it will touch each of us
directly or indirectly and drain the savings of
Americans. Many advances in research are not pursued
by larger drug companies whose economic models
favor palliative care (long-term repeat drug sales) over cures
and drugs over diagnostics while smaller companies
struggle to attract investment. InvestAcure's Common Need
Investment model has the potential to alleviate some of
this investment bottleneck. 70 million US adults have a
relative with Alzheimer's. If a small percentage of
this affinity
group invest their spare-change, billions of dollars will
be freed to fund approaches that
might otherwise be neglected. I'm thrilled to join
the InvestAcure team, to work with them to develop
this financial model to its full potential. I also hope to use
my experience with the JOBS Act and JOBS Act
3.0 legislation, that passed the House 406-4 on
July 17, 2018, to continue to
advocate for policies that speed the advancement of
Common Need Investment to create a brighter future for
all Americans."
"David is one of the world's top experts in capital markets and
the use of financial policy to solve many of the major problems we
face as a society. We are thrilled to have him join our team to
help realize the full potential of our vision for Common Need
Investment to ensure that financing is made available for companies
working on lifesaving drugs and therapeutics for Alzheimer's and
other complex diseases," said Max
Tokarsky, Founder & CEO of InvestAcure, PBC.
About David Weild IV
Mr. Weild is the Founder, Chairman and CEO of Weild
& Co., the firm that is revolutionizing investment banking by
pushing it to the cloud. The studies that Mr.
Weild co-authored were the first to identify the
long-term decline in equity capital formation in the United States and provided the core
arguments that gave rise to the JOBS Act. For these reasons, he is
frequently called "The Father of the JOBS Act." Mr. Weild
is a former Vice Chairman and executive committee member of The
NASDAQ Stock Market and spent years running major Wall Street
investment banking and equity capital markets businesses. He
is also Chairman Emeritus and an active Board Member of
Tuesday's Children, the charity that provides long-term recovery
services to 9/11 family members, victims of mass shootings,
and widows and orphans of U.S. military.
About InvestAcure, PBC
InvestAcure is a Public Benefit Corporation, with a vision to
see a world where drug companies are owned by millions of
spare-change investors committed to curing Alzheimer's. To realize
this goal, the company is building a spare-change investment
platform to enable those impacted by Alzheimer's to partner in the
search for a cure by rounding-up day-to-day transactions and
investing the spare change in clinical stage pharmaceuticals
working on promising drugs. This would help transition investment
leadership from a narrow group of profit-driven investors to a much
larger and stable investor base motivated primarily by the search
for a cure, leading to more clinical trials, more drugs and drug
combinations tested and progress to a cure.
For additional information about InvestAcure, PBC visit
www.investacure.com or email info@inverstacure.com.
To learn more about the big picture vision behind InvestAcure's
Common Need Investment model, read: Alzheimer's: what if drug
companies were owned by the millions waiting for a cure?
Bill Gates' venture philanthropy for
Alzheimer's is trailblazing — with Common Need Investment the rest
of us can do our part to fix a broken system and power the search
for a cure.
Related Links
InvestAcure, PBC
Alzheimer's: what if drug companies were owned by the millions
waiting for a cure? Bill Gates'
venture philanthropy for...
Related Video
http://www.youtube.com/watch?v=FqK3OtNybuU
View original content to download
multimedia:http://www.prnewswire.com/news-releases/former-vice-chairman-of-the-nasdaq-david-weild-joins-as-co-founder--vice-chairman-of-investacure-pbc-a-common-need-investment-firm-for-alzheimers-rd-300762330.html
SOURCE InvestAcure, PBC